WHO Approves Covaxin For Emergency Use
The World Health Organization granted emergency use authorisation for Bharat Biotech's Covid-19 vaccine Covaxin.
The WHO approved the vaccine’s use in people aged 18 and older on a two-dose schedule with four weeks between shots, according to a statement on Wednesday.
The Technical Advisory Group, an independent advisory committee of the WHO, had on Oct. 26 sought "additional clarifications" from the company for Covaxin to conduct a final "risk-benefit assessment" for emergency use authorisation of the vaccine.
India's active case load continued on its downward trajectory as fresh cases were dwarfed by daily recoveries for the fourth day in a row.
As many as 11,903 people tested positive for the coronavirus in the last 24 hours, according to the Health Ministry’s update as of 8 a.m. on Nov. 3.
That compares with 14,159 recoveries in the same day, taking active cases lower to 1.51 lakh. Active cases account for just 0.44% of India's total Covid tally, also lowest since Feb. 21.
Key Coronavirus Data
Total confirmed cases: 3,43,08,140
Total number of active cases: 1,51,209
Total patients cured/discharged/migrated: 3,36,97,740
Total deaths: 4,59,191
Number of fresh cases in last 24 hours: 11,903
Number of recoveries in a day: 14,159
Deaths recorded in a day: 311
Vaccines given in the last 24 hours: 41,16,230
Total vaccines administered: 1,07,29,66,315
RECOMMENDED FOR YOU
POPULAR